vcfirmsdirectory.com

Venture capital

Pappas Capital

Durham-based venture and commercial development firm that backs life science, agriculture and technology companies. It runs a flagship venture arm, custom fund vehicles and a university translational medicine program.

DurhamRegistered · Durham
New investments · 12 months
Fund vehiclesPublic
8
8 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: pappas-capital.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Pappas Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Pappas Capital right for your round?

Is Pappas Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
8
8 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

ASIA INNOVATION VENTURES, LPUS private fund · Active · United States · $84M gross assets · filed 31 Mar 2026
PAPPAS LIFE SCIENCE VENTURES VI, LPUS private fund · Active · United States · $33.3M gross assets · filed 31 Mar 2026
CHIESI VENTURES, LPUS private fund · Active · United States · $28.5M gross assets · filed 31 Mar 2026
A.M. PAPPAS LIFE SCIENCE VENTURES V, LPUS private fund · Active · United States · $9.6M gross assets · filed 31 Mar 2026
PV VI CEO FUND, LPUS private fund · Active · United States · $5.9M gross assets · filed 31 Mar 2026
A. M. PAPPAS LIFE SCIENCE VENTURES IV, LPUS private fund · Active · United States · $3M gross assets · filed 31 Mar 2026
PV V CEO FUND, LPUS private fund · Active · United States · $905.2K gross assets · filed 31 Mar 2026
PV IV CEO FUND, LPUS private fund · Active · United States · $147.5K gross assets · filed 31 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Pappas Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, Pappas Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

4DMTAchillionAclara BiosciencesAer TherapeuticsAfferentAktis OncologyAllievexAmplyxAntheraArenaand 67 more

Portfolio and exits

Every company Pappas Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Pappas Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Pappas Capital

Events where Pappas Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Pappas Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

29 Sep 2026New deal
31 Mar 2026Fund filingForm ADV filed by PAPPAS VENTURES: 8 private funds, $165.3M in gross assets.SEC Form ADV · public record

Founders also look at

Frequently asked questions

Pappas Capital is based in Durham, United States.

8 fund vehicles are on public registers (SEC adviser filings), including ASIA INNOVATION VENTURES, LP, PAPPAS LIFE SCIENCE VENTURES VI, LP and CHIESI VENTURES, LP.

Sectors: Life sciences, Food and agtech. From the firm’s own website.

Builds and funds next-generation life science companies from concept to market, with drug-development expertise guiding clinical and regulatory strategy. It also helps portfolio companies recruit talent and opens its industry network, and partners with universities to commercialize research. From the firm’s own website.

Pappas Capital lists 77 portfolio companies on its website, including 4DMT, Achillion, Aclara Biosciences, Aer Therapeutics and Afferent.

Firms whose websites list some of the same companies include Alta Partners, Canaan and Longitude Capital.

Know before Pappas Capital’s next round is announced.

PRO tracks Pappas Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Pappas CapitalGet Pappas Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.